search

Active clinical trials for "Adenoma"

Results 301-310 of 652

Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection...

Cancer Colorectal

The relative risk of colorectal cancer (CRC) is increased in first-degree relatives of patients with CRC or advanced adenoma. In the high-risk CCR population defined by a family history at the first stage of CRC or advanced adenoma before age 60, total colonoscopy is the recommended screening test. In France, the rate of screening colonoscopy in this population at high risk of CRC is insufficient, which limits the effectiveness of this targeted screening. The main reason for this low participation rate is that most patients undergoing RCC or advanced adenoma are unaware of the family implications of their diagnosis and therefore reluctant to disseminate this information to their patients Related matters. The need for a better perception of the personal risk of CRC in first-degree relatives of patients with CRC or advanced adenoma, with the expected coronary adherence to increasing screening, requires a good understanding of risk through Clear, adapted and comprehensible information that can be relayed personally by the case-index. The objective of this project is to develop a personalized prevention and screening program for the JRC in order to meet the needs of the relatives of the sick. The means of intervention that will be implemented respond to the need to better take into account the level of CRC risk in a family-based CRC screening and prevention approach adapted to a high-risk CRC group characterized by Family history at the first stage of CRC or advanced adenoma and, consequently, to improve the information of the subjects concerned by screening and prevention of CRC. The aim of the case-index education is to induce its intervention with its relatives to promote CCR screening. The use of the index case, as a means of providing information to relatives, implies an educational and psychological approach, based on evidence, but adapted and personalized.

Completed21 enrollment criteria

Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy

Bowel Preparation Scalethe Amount of Air Bubble1 more

To evaluate the efficacy, visibility of low volume polyethyleneglycol-simeticone (2-LPEG-S) for colonoscopy.

Completed8 enrollment criteria

Efficacy of Segmental Examination Twice of the Proximal Colon on Adenoma Detection

Colonic Polyps

Segmental examination twice of the proximal colon might be helpful to increase adenoma detection rate (ADR).

Completed6 enrollment criteria

Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments

Colon Cancer ScreeningColon Polyps2 more

The goal of this study is to compare two FDA approved distal colonoscope attachment devices, in order to identify which device can increase adenoma detection rate the most without increasing procedure time or risk.

Completed13 enrollment criteria

G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different...

Colorectal CancerAdenoma

The purpose of this study is to compare the adenoma detection rate of G-EYE™ high definition colonoscopy with that of standard high definition colonoscopy.

Completed12 enrollment criteria

EndoCuff-assisted Versus Standard Colonoscopy for Adenoma Detection

PolypAdenoma1 more

The EndoCuff is novel flexible cuff that can be attached to the distal tip of the colonoscope and helps to flatten large mucosal folds during withdrawal. The study hypothesis is that the use of the Endocuff (EC) increases the adenoma detection rate during colonoscopy. The study purpose is to compare EC-assisted colonoscopy with standard colonoscopy for polyp detection.

Completed7 enrollment criteria

Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy

Colorectal CancerPolyp1 more

To evaluate the safety of using the NaviAid™ G-Eye system during Colonoscopy

Completed13 enrollment criteria

Physical Activity Intervention With People at Increased Risk of Developing Colon Cancer

Colon PolypsColon Adenomas

The present study will use a randomised controlled trial design to investigate whether moderate to vigorous intensity physical activity (MVPA) will affect the physiological risk markers associated with the development of bowel cancer in individuals previously diagnosed with a bowel polyp. The study will also investigate the effects of the programme on long-term exercise behaviour and changes in psychological variables. A selected sample will also be part of individual interviews at baseline and 12 months to gauge narrative accounts of personal, psychological and sociological beliefs surrounding participation in physical activity. The findings of this study might inform better practices for the prevention of bowel cancer in high risk populations. After a screening colonoscopy, eligible participants will be randomised to either an active lifestyle programme (ALP) or a standard care group (SC). Participants in ALP will be offered supervised exercise sessions and motivational interviewing for 6 months. Intervention components will cease after 6 months, but participants will be followed-up at 12 months to investigate maintenance to physical activity over the long-term. The SC will not be offered the intervention until the end of the study. Participants in both groups will be invited for assessments at baseline, 3, 6, 9, and 12 months. These include measurements of body composition, cardiopulmonary fitness, physical activity behaviour, and psycho-social variables.

Completed12 enrollment criteria

Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis

Familial Adenomatous PolyposisDuodenal Neoplasms1 more

Duodenal carcinomas are the leading cause of mortality in patients with Familial Adenomatous Polyposis (FAP) who underwent prophylactic colorectal surgery. The purpose of this study is to determine wether celecoxib combined with ursodeoxycholic acid is an effective chemoprevention strategy to influence the progression of duodenal adenomas to carcinomas in patients with FAP.

Completed16 enrollment criteria

Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas

ResectableNon-functioning Pituitary Adenoma

The purpose of this study is to evaluate whether therapy with farletuzumab is effective and safe in the treatment of resectable, non-functioning pituitary adenomas.

Withdrawn8 enrollment criteria
1...303132...66

Need Help? Contact our team!


We'll reach out to this number within 24 hrs